PL330239A1 - Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment - Google Patents

Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment

Info

Publication number
PL330239A1
PL330239A1 PL97330239A PL33023997A PL330239A1 PL 330239 A1 PL330239 A1 PL 330239A1 PL 97330239 A PL97330239 A PL 97330239A PL 33023997 A PL33023997 A PL 33023997A PL 330239 A1 PL330239 A1 PL 330239A1
Authority
PL
Poland
Prior art keywords
reserption
growt
coherent
bone
cyclic
Prior art date
Application number
PL97330239A
Inventor
Erik Fink Eriksen
Anne-Marie Kappelgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL330239A1 publication Critical patent/PL330239A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL97330239A 1996-05-31 1997-05-29 Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment PL330239A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK62396 1996-05-31

Publications (1)

Publication Number Publication Date
PL330239A1 true PL330239A1 (en) 1999-05-10

Family

ID=8095682

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97330239A PL330239A1 (en) 1996-05-31 1997-05-29 Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment

Country Status (14)

Country Link
EP (1) EP0907374A1 (en)
JP (1) JP2000512274A (en)
KR (1) KR20000016204A (en)
CN (1) CN1220609A (en)
AU (1) AU3025997A (en)
BR (1) BR9709499A (en)
CA (1) CA2257174A1 (en)
CZ (1) CZ383298A3 (en)
HU (1) HUP9904049A3 (en)
IL (1) IL126983A0 (en)
NO (1) NO985573L (en)
PL (1) PL330239A1 (en)
WO (1) WO1997046252A1 (en)
ZA (1) ZA974785B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (en) 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
US6784158B1 (en) 1998-06-09 2004-08-31 Novo Nordisk A/S Method for preparing a compound with growth hormone releasing properties
JP4574849B2 (en) * 1998-06-09 2010-11-04 サファイア セラピューティクス，インコーポレイティド Method for preparing compounds having growth hormone releasing properties
JP2001031635A (en) 1999-07-14 2001-02-06 Ajinomoto Co Inc Method for producing optically active N-protected-N-methyl-phenylalanine derivative
DE60140285D1 (en) 2000-05-31 2009-12-10 Pfizer Prod Inc Use of growth hormone secretagogues to promote the mobility of the digestive tract
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
CN101657436A (en) 2007-02-09 2010-02-24 特兰齐姆制药公司 macrocyclic ghrelin receptor modulators and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
DK0559751T3 (en) * 1990-11-26 1997-10-06 Robert R Recker Treatment of osteoporosis using growth hormone releasing factor (GRF) in combination with parathyroid hormone (PTH)
HUT75224A (en) * 1993-10-19 1997-04-28 Merck & Co Inc Combination of bisphosphonates and growth hormone secretagogues

Also Published As

Publication number Publication date
CZ383298A3 (en) 1999-07-14
WO1997046252A1 (en) 1997-12-11
NO985573D0 (en) 1998-11-27
CN1220609A (en) 1999-06-23
ZA974785B (en) 1998-01-22
IL126983A0 (en) 1999-09-22
HUP9904049A2 (en) 2000-04-28
NO985573L (en) 1999-01-29
EP0907374A1 (en) 1999-04-14
JP2000512274A (en) 2000-09-19
HUP9904049A3 (en) 2000-07-28
BR9709499A (en) 1999-08-10
KR20000016204A (en) 2000-03-25
AU3025997A (en) 1998-01-05
CA2257174A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
EP0767624A4 (en) Devices and methods for bone/tissue preparation
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
IL131543A0 (en) Cosmetic methods and compositions for preventing and treating chronological aging in human skin
IL128128A (en) Composition comprising insulin and insulin-like growth factor (i-igf)
IL125981A0 (en) Improved tissue destruction in cryosurgery
EP1047442A4 (en) Bone morphogenetic proteins and their use in bone growth
ZA947138B (en) Skin care method and composition
AU5799099A (en) Method and devices for use in bone fixation procedures
PL332547A1 (en) Skin care compositions containing an acid and retinoide
HU9801511D0 (en) Human semaphorin-l (h-sema-l) and corresponding semaphorine in other species
GB2317182B (en) Sulfated polysaccharides and uses thereof in medical treatment
PL330239A1 (en) Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment
GB2325461B (en) Medical sharps and blades removal and containment structure
AU135003S (en) An abutment for use in dental implant
IL111554A (en) Methods and compositions for hair treatment
GB2317980B (en) Analogue multiplier using MOSFETs in nonsaturation region and current mirror
ZA971718B (en) Combination therapy to prevent bone loss-progesterone and estrogen agonists
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
ZA947145B (en) Skin care method and composition
GB9614958D0 (en) Cosmetic skin treatment and apparatus therefor
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB2338230B (en) Medical sharps and blades removal and containment structure
GB9210405D0 (en) Improvements in and relating to surgical sutures
GB9620530D0 (en) Back and neck treatment device
GB9614230D0 (en) Disposable all in one toothbrush and paste